ELISA system for human endothelial lipase

Clinical Chemistry

Volumn 58, Issue 12, 2012, Pages 1656-1664

  Ishida, Tatsuro ^a   Miyashita, Kazuya ^b   Shimizu, Mamoru ^b   Kinoshita, Noriaki ^b   Mori, Kenta ^a   Sun, Li ^a   Yasuda, Tomoyuki ^a   Imamura, Shigeyuki ^c   Nakajima, Katsuyuki ^d   Stanhope, Kimber L ^e   Havel, Peter J ^e   Hirata, Ken Ichi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Immuno Biological Laboratories Co Ltd   (Japan)

^c TOKYO UNIVERSITY OF MARINE SCIENCE AND TECHNOLOGY   (Japan)

^d GUNMA UNIVERSITY   (Japan)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LIPASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CALIBRATION; CARDIOVASCULAR DISEASE; CHO CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; NONHUMAN; STANDARD;

ANIMALS; ANTIBODIES, MONOCLONAL; CHO CELLS; CHOLESTEROL, HDL; CLINICAL ENZYME TESTS; CORONARY DISEASE; CRICETINAE; CRICETULUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LIPASE; MICE; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY;

CRICETULUS GRISEUS; MUS;

EID: 84870324304     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.187914     Document Type: Article

References (40)

1. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 1986;256:2835-8.
2. Assmann G, Schulte H, von Eckardstein A, Huang Y. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk: the PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996;124 Suppl:S11-20.
3. Curb JD, Abbott RD, Rodriguez BL, Masaki K, Chen R, Sharp DS, et al. A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res 2004;45:948-53.
4. Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density sub-fractions: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2001;104:1108-13.
5. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS:23). BMJ 1998;316:823-8.
6. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr., Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-39.
7. Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007;357:1301-10.
8. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78.
9. Davis CE, Gordon D, LaRosa J, Wood PD, Halperin M. Correlations of plasma high-density lipoprotein cholesterol levels with other plasma lipid and lipoprotein concentrations. Circulation 1980;62:IV24-30.
10. Hirata K, Dichek HL, Cioffi JA, Choi SY, Leeper NJ, Quintana L, et al. Cloning of a unique lipase from endothelial cells extends the lipase gene family. J Biol Chem 1999;274:14170-5.
11. Jaye M, Lynch KJ, Krawiec J, Marchadier D, Maugeais C, Doan K, et al. A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet 1999;21:424-8.
12. Choi SY, Hirata K, Ishida T, Quertermous T, Cooper AD. Endothelial lipase: a new lipase on the block. J Lipid Res 2002;43:1763-9.
13. Yasuda T, Ishida T, Rader DJ. Update on the role of endothelial lipase in HDL metabolism, reverse cholesterol transport, and atherosclerosis. Circ J 2010;74:2263-70.
14. Ishida T, Choi S, Kundu RK, Hirata K, Rubin EM, Cooper AD, et al. Endothelial lipase is a major determinant of HDL level. J Clin Invest 2003;111:347-55.
15. Badellino KO, Wolfe ML, Reilly MP, Rader DJ. Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis. PLoS Med 2006;3:e22.
16. Kojima Y, Ishida T, Sun L, Yasuda T, Toh T, Rikitake Y, et al. Pitavastatin decreases expression of endothelial lipase both in vitro and in vivo. Cardiovasc Res 2010;87:385-93.
17. Edmondson AC, Brown RJ, Kathiresan S, Cupples LA, Demissie S, Manning AK, et al. Loss-offunction variants in endothelial lipase are a cause of elevated HDL cholesterol in humans. J Clin Invest 2009;119:1042-50.
18. Shimizu M, Kanazawa K, Hirata K, Ishida T, Hiraoka E, Matsuda Y, et al. Endothelial lipase gene polymorphism is associated with acute myocardial infarction, independently of high-density lipoprotein-cholesterol levels. Circ J 2007;71:842-6.
19. Tang NP, Wang LS, Yang L, Zhou B, Gu HJ, Sun QM, et al. Protective effect of an endothelial lipase gene variant on coronary artery disease in a Chinese population. J Lipid Res 2008;49:369-75.
20. Brown RJ, Edmondson AC, Griffon N, Hill TB, Fuki IV, Badellino KO, et al. A naturally occurring variant of endothelial lipase associated with elevated HDL exhibits impaired synthesis. J Lipid Res 2009;50:1910-6.
21. Vergeer M, Cohn DM, Boekholdt SM, Sandhu MS, Prins HM, Ricketts SL, et al. Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVT. Atherosclerosis 2010;211:558-64.
22. Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK, et al. Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study. Lancet 2012;380:572-80.
23. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010;466:707-13.
24. Brown RJ, Schultz JR, Ko KW, Hill JS, Ramsamy TA, White AL, et al. The amino acid sequences of the carboxyl termini of human and mouse hepatic lipase influence cell surface association. J Lipid Res 2003;44:1306-14.
25. Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009;119:1322-34.
26. Imamura S, Kobayashi J, Sakasegawa S, Nohara A, Nakajima K, Kawashiri M, et al. A novel method for measuring human hepatic lipase activity in postheparin plasma. J Lipid Res 2007;48:453-7.
27. Kotani K, Adachi S, Tsuzaki K, Sakane N. Relationship between serum preheparin lipoprotein lipase mass, plasma glucose and metabolic syndrome in older subjects. Age Ageing 2009;38:123-6.
28. Tornvall P, Olivecrona G, Karpe F, Hamsten A, Olivecrona T. Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins. Arterioscler Thromb Vasc Biol 1995;15:1086-93.
29. Hirata K, Ishida T, Matsushita H, Tsao PS, Quertermous T. Regulated expression of endothelial cell-derived lipase. Biochem Biophys Res Commun 2000;272:90-3.
30. Kojma Y, Hirata K, Ishida T, Shimokawa Y, Inoue N, Kawashima S, et al. Endothelial lipase modulates monocyte adhesion to the vessel wall: a potential role in inflammation. J Biol Chem 2004;279:54032-8.
31. Hara T, Ishida T, Kojima Y, Tanaka H, Yasuda T, Shinohara M, et al. Targeted deletion of endothelial lipase increases HDL particles with anti-inflammatory properties both in vitro and in vivo. J Lipid Res 2011;52:57-67.
32. Paradis ME, Badellino KO, Rader DJ, Deshaies Y, Couture P, Archer WR, et al. Endothelial lipase is associated with inflammation in humans. J Lipid Res 2006;47:2808-13.
33. Badellino KO, Wolfe ML, Reilly MP, Rader DJ. Endothelial lipase is increased in vivo by inflammation in humans. Circulation 2008;117:678-85.
34. Qiu G, Hill JS. Atorvastatin decreases lipoprotein lipase and endothelial lipase expression in human THP-1 macrophages. J Lipid Res 2007;48:2112-22.
35. Jin W, Sun GS, Marchadier D, Octtaviani E, Glick JM, Rader DJ. Endothelial cells secrete triglyceride lipase and phospholipase activities in response to cytokines as a result of endothelial lipase. Circ Res 2003;92:644-50.
36. Griffon N, Jin W, Petty TJ, Millar J, Badellino KO, Saven JG, et al. Identification of the active form of endothelial lipase, a homodimer in a head-to-tail conformation. J Biol Chem 2009;284:23322-30.
37. Jin W, Fuki IV, Seidah NG, Benjannet S, Glick JM, Rader DJ. Proprotein convertases are responsible for proteolysis and inactivation of endothelial lipase. J Biol Chem 2005;280:36551-9.
38. Shimamura M, Matsuda M, Yasumo H, Okazaki M, Fujimoto K, Kono K, et al. Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase. Arterioscler Thromb Vasc Biol 2007;27:366-72.
39. McCoy MG, Sun GS, Marchadier D, Maugeais C, Glick JM, Rader DJ. Characterization of the lipolytic activity of endothelial lipase. J Lipid Res 2002;43:921-9.
40. Fuki IV, Blanchard N, Jin W, Marchadier DH, Millar JS, Glick JM, Rader DJ. Endogenously produced endothelial lipase enhances binding and cellular processing of plasma lipoproteins via heparan sulfate proteoglycan-mediated pathway. J Biol Chem 2003;278:34331-8.